The table below shows IDEAYA Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$75.17M
-$60.34M
-$43.81M
-$27.84M
-$19.65M
-$13.72M
Capital expenditure
$967.00K
$1.33M
$1.32M
$43.00K
$401.00K
$1.00M
Investing cash flow
$118.95M
$79.82M
-$353.97M
$23.52M
-$17.76M
$36.44M
Dividends paid
-
-
-
-
IDYA operating cash flow (10-K history)
IDEAYA Biosciences, Inc. reported operating cash flow of -$71.10M for fiscal year 2025. That is up 71.3% from -$247.58M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$12.22M (FY 2017) to -$71.10M. Figures come from the company's audited annual reports as filed with the SEC.